WCM
GILD icon

Winton Capital Management’s Gilead Sciences GILD Stock Holding History

Winton Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$42.7M Buy
602,120
+138,197
+30% +$10.8M 0.29% 134
2013
Q4 		$34.8M Buy
463,923
+136,331
+42% +$9.49M 0.31% 117
2013
Q3 		$20.6M Sell
327,592
-89,541
-21% -$5.35M 0.25% 153
2013
Q2 		$21.4M Buy
+417,133
New +$21.7M 0.26% 146

Other funds holding GILD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Winton Capital Management's GILD Position: Q1 2014 in Review

Winton Capital Management increased its Gilead Sciences (GILD) stake by 30% in Q1 2014, buying an estimated $10.8M and bringing the position to 602,120 shares worth $42.7M. The position accounts for 0.29% of the portfolio, ranked #134.

Winton Capital Management first reported a position in GILD in Q2 2013 and has held it in 4 quarters since. 1,189 funds tracked by Wall St. Rank hold GILD as of Q1 2014.

  • Winton Capital Management held 602,120 shares of Gilead Sciences worth $42.7M as of Q1 2014.
  • Winton Capital Management bought 138,197 Gilead Sciences shares in Q1 2014, an estimated $10.8M.
  • Gilead Sciences made up 0.29% of Winton Capital Management's portfolio in Q1 2014, its #134 holding.
  • Winton Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 4 quarters since.
  • 1,189 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.